Probiodrug AG 28.11.2014 14:00 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Probiodrug AG Halle (Saale), Germany Handelsregister: Amtsgericht Stendal, HRB 213719 (Commercial Register: Local Court of Stendal, HRB 213719) ISIN: DE0007921835 Publication in accordance with sec. 26 para 1 sentence 1 WpHG (Wertpapierhandelsgesetz - German Securities Trading Act) Publication of a notification according to sec. 27a WpHG HBM Healthcare Investments (Cayman) Ltd, George Town, Grand Cayman, Cayman Islands, and HBM Healthcare Investments AG, Zug, Switzerland, informed our company on November 25, 2014 pursuant to sec. 27a WpHG in relation to their voting rights notifications pursuant to sec. 21, 22 WpHG dated November 4, 2014 and November 5, 2014 and the exceeding of the threshold of 10% of the voting rights in Probiodrug AG, as follows: 1. The investment is intended for generating trade profits. 2. We do not intend to obtain additional voting rights by way of acquisition or otherwise within the next 12 months. 3. We do not seek to exert influence on the composition of administrative, management and supervisory bodies of the issuer Probiodrug AG. 4. We do not seek to achieve substantial changes of the capital structure of Probiodrug AG, particularly in relation to the ratio of equity financing and debt financing and the dividend policy. As regards the source of the funds used, we declare as follows: The funds are 100% equity capital (Eigenkapital) of HBM Healthcare Investments (Cayman) Ltd. Halle (Saale), in November 2014 The Management 28.11.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English Company: Probiodrug AG Weinbergweg 22 06120 Halle/Saale Germany Internet: www.probiodrug.de End of Announcement DGAP News-Service
---------------------------------------------------------------------------
---------------------------------------------------------------------------
Probiodrug AG Halle (Saale), Germany Handelsregister: Amtsgericht Stendal, HRB 213719 (Commercial Register: Local Court of Stendal, HRB 213719) ISIN: DE0007921835 Publication in accordance with sec. 26 para 1 sentence 1 WpHG (Wertpapierhandelsgesetz - German Securities Trading Act) Publication of a notification according to sec. 27a WpHG HBM Healthcare Investments (Cayman) Ltd, George Town, Grand Cayman, Cayman Islands, and HBM Healthcare Investments AG, Zug, Switzerland, informed our company on November 25, 2014 pursuant to sec. 27a WpHG in relation to their voting rights notifications pursuant to sec. 21, 22 WpHG dated November 4, 2014 and November 5, 2014 and the exceeding of the threshold of 10% of the voting rights in Probiodrug AG, as follows: 1. The investment is intended for generating trade profits. 2. We do not intend to obtain additional voting rights by way of acquisition or otherwise within the next 12 months. 3. We do not seek to exert influence on the composition of administrative, management and supervisory bodies of the issuer Probiodrug AG. 4. We do not seek to achieve substantial changes of the capital structure of Probiodrug AG, particularly in relation to the ratio of equity financing and debt financing and the dividend policy. As regards the source of the funds used, we declare as follows: The funds are 100% equity capital (Eigenkapital) of HBM Healthcare Investments (Cayman) Ltd. Halle (Saale), in November 2014 The Management 28.11.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English Company: Probiodrug AG Weinbergweg 22 06120 Halle/Saale Germany Internet: www.probiodrug.de End of Announcement DGAP News-Service
---------------------------------------------------------------------------
